Overcoming Inequities in Obesity: What Don't We Know That We Need to Know?

Health Education & Behavior : the Official Publication of the Society for Public Health Education
Shiriki Kumanyika

Abstract

Efforts to combat the U.S. obesity epidemic have been ongoing in earnest for nearly two decades, informed by a substantial body of knowledge and guided by numerous programmatic and policy recommendations. Yet, although there are some bright spots, I sense frustration in the public health community with the overall lack of clear progress in lowering high obesity prevalence. The fact that something is missing from current approaches is undeniable and must be a continued source of inquiry. This commentary focuses attention on an aspect that is especially concerning-inequities that predispose to a notably higher obesity prevalence in U.S. racial/ethnic minority populations compared with non-Hispanic Whites. Critical analyses of what we are doing now can point the way to improvements in both individually oriented and policy, systems, and environmental change strategies to overcome the epidemic. Success will require working with communities to co-design relevant and realistic interventions as well as broader social changes that address underlying causes.

References

Jun 1, 1991·The American Journal of Clinical Nutrition·S K KumanyikaS K Kumanyaka
Jan 1, 1987·Epidemiologic Reviews·S Kumanyika
Oct 29, 1993·Annals of the New York Academy of Sciences·S Kumanyika
Oct 1, 1993·Annals of Internal Medicine·S K Kumanyika
Feb 7, 1996·American Journal of Health Promotion : AJHP·D Stokols
Mar 29, 2001·Annual Review of Public Health·S K Kumanyika
Feb 12, 2002·Obesity Research·Shiriki K KumanyikaUNKNOWN TONE Cooperative Research Group
Mar 16, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S KumanyikaUNKNOWN Public Health Approaches to the Prevention of Obesity (PHAPO) Working Group of the International Obesity Task Force (IOTF)
May 27, 2005·Preventive Medicine·Shiriki K KumanyikaMarjorie A Bowman
Mar 1, 1994·Obesity Research·S K Kumanyika
Jan 20, 2006·Obesity Research·Shiriki K KumanyikaMelicia C Whitt-Glover
Oct 28, 2009·Archives of Internal Medicine·Shiriki K KumanyikaXiaoying Wu
Apr 21, 2012·Journal of Obesity·Trevor J B DummerLouise Parker
Sep 10, 2014·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·B C WingoJ Ard
Sep 10, 2014·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A KongM L Fitzgibbon
Sep 20, 2015·American Journal of Preventive Medicine·S Sonia ArteagaWarren J Strauss
Jun 9, 2016·JAMA : the Journal of the American Medical Association·Cynthia L OgdenKatherine M Flegal
Jul 21, 2017·American Journal of Public Health·Ann BullockSpero Manson
Mar 24, 2018·JAMA : the Journal of the American Medical Association·Craig M HalesCynthia L Ogden
Jun 19, 2019·JAMA : the Journal of the American Medical Association·Liping PanHeidi M Blanck

❮ Previous
Next ❯

Citations

Sep 17, 2020·Childhood Obesity·Shiriki K Kumanyika
Mar 19, 2021·Clinical Obesity·Roohi Y KharofaKristen A Copeland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved